GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this drug is unlikely to be needed for those heart ...
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
A team led by a UNL researcher is working to develop a wearable monitoring device that contains multiple types of sensors to ...
The exposure-response model is a nonlinear, mixed-effects Emax model that included repeated measurements of RPF for each subject in the study (>200 data points), resulting in a modeled E max (maximum ...
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor ...
Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.
excessive levels can heighten the risk of heart disease and stroke. In this article, we look at the top 5 dry fruits that you ...
The first new guidelines in 10 years from the American Stroke Association for people and doctors reflect a better ...
According to the American Heart Association, angina is not an illness but a symptom of heart disease. "Angina is chest pain or ... besides prescribing certain medications or asking them to change to a ...
It could also help some patients with kidney transplants get them, as well as potentially other organ-failure ... other heart ...